Literature DB >> 11368183

Calcium ion downregulates soluble guanylyl cyclase activity: evidence for a two-metal ion catalytic mechanism.

L Serfass1, H S Carr, L M Aschenbrenner, J N Burstyn.   

Abstract

The inhibition of soluble guanylyl cyclase by Ca2+ has been kinetically characterized and the results support a two-metal-ion catalytic mechanism for formation of cGMP. Ca2+ reversibly inhibits both the basal and NO-stimulated forms of bovine lung soluble guanylyl cyclase. Inhibition is independent of the activator identity and concentration, revealing that Ca2+ interacts with a site independent of the heme regulatory site. Inhibition by Ca2+ is competitive with respect to Mg2+ in excess of substrate, with Kis values of 29 +/- 4 and 6.6 +/- 0.6 microM for the basal and activated states, respectively. Ca2+ inhibits noncompetitively with respect to the substrate MgGTP in both activity states. The qualitatively similar inhibition pattern and quantitatively different Ki values between the basal and NO-stimulated states suggest that the Ca2+ binding site undergoes some structural modification upon activation of the enzyme. The competitive nature of Ca2+ inhibition with respect to excess Mg2+ is consistent with a two-metal-ion mechanism for cyclization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368183     DOI: 10.1006/abbi.2000.2090

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Direct chemiluminescence detection of nitric oxide in aqueous solutions using the natural nitric oxide target soluble guanylyl cyclase.

Authors:  Yakov Y Woldman; Jian Sun; Jay L Zweier; Valery V Khramtsov
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

2.  Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Authors:  Saumya Ramanathan; Stacy Mazzalupo; Scott Boitano; William R Montfort
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

Review 3.  The Disease-Modifying Role of Taurine and Its Therapeutic Potential in Coronavirus Disease 2019 (COVID-19).

Authors:  Larissa E van Eijk; Annette K Offringa; Maria-Elena Bernal; Arno R Bourgonje; Harry van Goor; Jan-Luuk Hillebrands
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor.

Authors:  William R Montfort; Jessica A Wales; Andrzej Weichsel
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

5.  Detection of nitric oxide production in cell cultures by luciferin-luciferase chemiluminescence.

Authors:  Yakov Y Woldman; Tim D Eubank; Andrew J Mock; Natalia C Stevens; Saradhadevi Varadharaj; Jenifer Turco; Mikhail A Gavrilin; Bruce R Branchini; Valery V Khramtsov
Journal:  Biochem Biophys Res Commun       Date:  2015-08-04       Impact factor: 3.575

6.  Nitric oxide stimulation of cGMP accumulation in myometrial cells from pregnant women is antagonized by oxytocin.

Authors:  Iain L O Buxton
Journal:  Proc West Pharmacol Soc       Date:  2008

7.  The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols.

Authors:  Thomas W Miller; Melisa M Cherney; Andrea J Lee; Nestor E Francoleon; Patrick J Farmer; S Bruce King; Adrian J Hobbs; Katrina M Miranda; Judith N Burstyn; Jon M Fukuto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

Review 8.  Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.

Authors:  Natasha M Rogers; Franziska Seeger; Elsa D Garcin; David D Roberts; Jeffrey S Isenberg
Journal:  Front Physiol       Date:  2014-04-04       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.